OPK - Opko Health, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
4.94
+0.07 (+1.44%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close4.87
Open4.83
Bid4.87 x 800
Ask4.95 x 300
Day's Range4.80 - 5.01
52 Week Range4.50 - 12.15
Volume6,046,855
Avg. Volume4,973,683
Market Cap2.76B
Beta2.24
PE Ratio (TTM)N/A
EPS (TTM)-0.15
Earnings DateNov 6, 2017 - Nov 10, 2017
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est12.75
Trade prices are not sourced from all markets
  • Cramer's lightning round: After Opko Health's quarter, it...
    CNBC Videos2 days ago

    Cramer's lightning round: After Opko Health's quarter, it...

    Jim Cramer sped through his take on callers' favorite stocks, including a struggling medical play.

  • Cramer's lightning round: After Opko Health's quarter, it's a 'neighborhood of pain'
    CNBC2 days ago

    Cramer's lightning round: After Opko Health's quarter, it's a 'neighborhood of pain'

    Jim Cramer sped through his take on callers' favorite stocks, including a struggling medical play.

  • Is Opko Health Inc. a Buy?
    Motley Fool3 days ago

    Is Opko Health Inc. a Buy?

    Has the market beaten this healthcare stock into bargain territory?

  • Business Wire4 days ago

    Xenetic Biosciences Reports 2017 Third Quarter Financial Results and Provides Corporate Update

    Xenetic Biosciences, Inc. , a clinical-stage biopharmaceutical company focused on the discovery, research and development of next-generation biologic drugs and novel orphan oncology therapeutics, announced today its unaudited financial results for the quarter ended September 30, 2017.

  • Thomson Reuters StreetEvents7 days ago

    Edited Transcript of OPK earnings conference call or presentation 8-Nov-17 9:30pm GMT

    Q3 2017 OPKO Health Inc Earnings Call

  • OPKO Health (OPK) Posts Wider-Than-Estimated Loss in Q3
    Zacks9 days ago

    OPKO Health (OPK) Posts Wider-Than-Estimated Loss in Q3

    OPKO Health (OPK) posts lackluster Q3 numbers due to rising operating expenses owing to investment associated to the launch of RAYALDEE, and consistent investment in the pharmaceutical pipeline.

  • ACCESSWIRE9 days ago

    Today’s Research Reports on Trending Tickers: Opko Health and Omeros Corporation

    NEW YORK, NY / ACCESSWIRE / November 10, 2017 / U.S. markets record rally stalled on Thursday on concerns of a delay in President Trump's proposed tax plan. The Dow Jones Industrial Average declined 0.43 ...

  • SmarterAnalyst10 days ago

    Opko Health Investors Got Spooked Today, But Analyst Louise Chen Bets on Long-Term Sales Potential

    Opko Health Inc. (NASDAQ:OPK) delivered a sore sight to the Street yesterday with a sharp third quarter miss in earnings that has sent investors scrambling away in the aftermath. However, Cantor analyst Louise Chen makes a confident case for the drug maker's "underappreciated" earnings potential.

  • OPKO Health, Inc. is trading above its 50 day moving average : OPK-US : November 9, 2017
    Capital Cube10 days ago

    OPKO Health, Inc. is trading above its 50 day moving average : OPK-US : November 9, 2017

    Categories: Europe Stock Alerts Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for OPKO Health, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish ... Read more (Read more...)

  • SmarterAnalyst10 days ago

    Opko Health Inc. (OPK) Announces 3Q:17 Financial Results; Shares Tumble

    Opko Health Inc. (NASDAQ:OPK) reports operating and financial results for the three months ended September 30, 2017.

  • GlobeNewswire10 days ago

    OPKO Health Reports 2017 Third Quarter Highlights and Financial Results

    RAYALDEE total prescriptions increased 66% in Q3 2017 compared with Q2 2017 4 Kscore utilization increased 19% in Q3 2017 compared with Q3 2016 4 Kscore TV ads in the Northeast to begin November 21 Submitted ...

  • Capital Cube15 days ago

    OPKO Health, Inc. – Value Analysis (NASDAQ:OPK) : November 3, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives OPKO Health, Inc. a score of 34. Our analysis is based on comparing OPKO Health, Inc. with the following peers – TESARO, Inc., Johnson & Johnson, Abbott Laboratories, Regeneron Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Limited Sponsored ADR, Novelion Therapeutics Inc., Alnylam Pharmaceuticals, Inc, Ardelyx, ... Read more (Read more...)

  • Capital Cube17 days ago

    ETFs with exposure to OPKO Health, Inc. : November 2, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to OPKO Health, Inc. Here are 5 ETFs with the largest exposure to OPK-US. Comparing the performance and risk of OPKO Health, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube17 days ago

    OPKO Health, Inc. breached its 50 day moving average in a Bearish Manner : OPK-US : November 2, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for OPKO Health, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish ... Read more (Read more...)

  • Capital Cubelast month

    ETFs with exposure to OPKO Health, Inc. : October 16, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to OPKO Health, Inc. Here are 5 ETFs with the largest exposure to OPK-US. Comparing the performance and risk of OPKO Health, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • OPKO Health (OPK) Signs New Agreement with Japan Tobacco
    Zackslast month

    OPKO Health (OPK) Signs New Agreement with Japan Tobacco

    OPKO Health's (OPK) new agreement with Japan Tobacco will enhance prospects of its kidney drug RAYALDEE in Japan.

  • American City Business Journalslast month

    Opko Health inks deal to bring new drug to Japan, generate more than $100M in revenue

    Opko Health Inc. has entered into an exclusive agreement to bring its latest drug to Japan. Rayaldee, a drug aimed at treating a thyroid condition the Miami biotech firm released in November, will be sold in the Asian nation by Japan Tobacco Inc., per a deal with Opko subsidiary EirGen Pharma, announced Thursday. The agreement requires Japan Tobacco to make an upfront payment of $6 million to Opko (OPK) in addition to another $6 million when Opko begins the phase 2 study of Rayaldee in U.S. dialysis patients.

  • GlobeNewswirelast month

    OPKO Health Enters into Exclusive Agreement with Japan Tobacco to Develop and Commercialize RAYALDEE® in Japan

    MIAMI, Oct. 12, 2017-- OPKO Health, Inc. announced that its subsidiary EirGen Pharma has entered into an exclusive agreement with Japan Tobacco Inc. for the development and commercialization in Japan of ...

  • American City Business Journalslast month

    These are the highest-paid tech executives in South Florida

    Maybe you’ve heard: The technology industry is flush with cash. The Business Journal pulled the Securities and Exchange Commission filings for the region’s public technology companies to find the 2016 compensation packages of the highest-paid executives. In all, 23 executives from seven publicly traded tech firms took home total individual compensation ranging from $546,424 to more than $25 million.

  • Capital Cube2 months ago

    ETFs with exposure to OPKO Health, Inc. : October 3, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to OPKO Health, Inc. Here are 5 ETFs with the largest exposure to OPK-US. Comparing the performance and risk of OPKO Health, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • ACCESSWIRE2 months ago

    Today's Research Reports on Trending Tickers: Opko Health and Pulmatrix

    NEW YORK, NY / ACCESSWIRE / September 27, 2017 / U.S. markets were mixed Tuesday, with the Dow Jones Industrial Average falling for the fourth consecutive session for the first time since June. The Dow ...

  • OPKO Health, Inc. is trading above its 50 day moving average : OPK-US : September 27, 2017
    Capital Cube2 months ago

    OPKO Health, Inc. is trading above its 50 day moving average : OPK-US : September 27, 2017

    Categories: Europe Stock Alerts Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for OPKO Health, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish ... Read more (Read more...)

  • Capital Cube2 months ago

    ETFs with exposure to OPKO Health, Inc. : September 22, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to OPKO Health, Inc. Here are 5 ETFs with the largest exposure to OPK-US. Comparing the performance and risk of OPKO Health, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • OPKO Health, Inc. :OPK-US: Earnings Analysis: Q2, 2017 By the Numbers : September 21, 2017
    Capital Cube2 months ago

    OPKO Health, Inc. :OPK-US: Earnings Analysis: Q2, 2017 By the Numbers : September 21, 2017

    Categories: Yahoo FinanceGet free summary analysis OPKO Health, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of OPKO Health, Inc. – TESARO, Inc., Regeneron Pharmaceuticals, Inc., Teva Pharmaceutical Industries Limited Sponsored ADR, Ardelyx, Inc., Laboratory Corporation of America Holdings, Novelion Therapeutics Inc., Alnylam Pharmaceuticals, Inc ... Read more (Read more...)

  • ACCESSWIRE2 months ago

    Today's Research Reports on Trending Tickers: Amicus Therapeutics and Opko Health

    NEW YORK, NY / ACCESSWIRE / September 21, 2017 / U.S. markets closed at another record high on Wednesday as bank stocks surged after the Federal Reserve announcement kept the possibility of a December ...